Innovation

Our constant commitment.

By improving the way therapies are formulated and used, we can have the biggest impact.

Innovate to improve

We engage with customers and clinicians to understand unmet needs. We think outside the box, challenge the status quo and accelerate the adoption of new solutions to improve therapies and make an impact.

Our Swiss Innovation Laboratory approach - uniquely designed with the contribution of our passionate KOLs continues to deliver innovative drug formulations providing best-in-class solutions to physicians in peri-operative and critical-care medicine, with unparalleled value to patients.
It is an opportunity to explore new avenues for such therapies and novel therapeutic areas in which our scientific and industrial capabilities can be applied to solve significant unmet clinical needs. This fact calls on us the importance of thinking broadly and worldwide when considering new developments and projects. Our original Swiss Lab of Global Innovation concept is becoming a platform with an ambition to expand worldwide and improve the patients’ experience wherever needed.
The Company has a proven track-record of innovation, leveraging on:
- An experienced R&D department with 30+ dedicated professionals which have developed a portfolio of 16 patents over the last years
- A full-fledged regulatory department, with a solid track record in different countries (high trust score with FDA) and an average of 50+ marketing authorizations p.a. completed over the last years
- A proven track record of innovation with a visible pipeline of new launches in Europe, the US and the rest of the world between 2023 and 2025
While recognizing the importance of innovation, we constantly invest in the latest technologies and employee training to support scientific and industrial processes and quickly respond to the latest medical discoveries and market requests.

A new way of living innovation

A new way of experiencing innovation will allow us to reach the patients and the market through our products, following lasting trends in patient care and grounded in clinicians’ needs.

Product
Service
Digital
Talent
Technology

Innovation Cluster

to strengthen our ability to innovate in any business context

It is an interdisciplinary team led by our Chief Innovation Officer, capable of proposing solutions that allow the company to reach the markets and patients by following, but also anticipating, the evolution of medical technologies and therapies. We bring our research and development, regulatory, clinical and medical people together in an innovation cluster, creating a more collaborative and creative work environment.